Vitamin D in Corona Virus Disease 2019 (COVID-19) Related Multisystem Inflammatory Syndrome in Children (MIS-C)

Multisystem Inflammatory Syndrome in children (MIS-C) is a rare but devastating complication of coronavirus disease 19 (COVID-19). The development of prognostic biomarkers and more importantly the implementation of new treatment modalities would have a significant impact in clinical practice regardi...

Full description

Bibliographic Details
Main Authors: Gavriela Feketea, Vasiliki Vlacha, Ioana Corina Bocsan, Emilia Vassilopoulou, Luminita Aurelia Stanciu, Mihnea Zdrenghea
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.648546/full
_version_ 1818439210897506304
author Gavriela Feketea
Gavriela Feketea
Vasiliki Vlacha
Ioana Corina Bocsan
Emilia Vassilopoulou
Luminita Aurelia Stanciu
Mihnea Zdrenghea
Mihnea Zdrenghea
author_facet Gavriela Feketea
Gavriela Feketea
Vasiliki Vlacha
Ioana Corina Bocsan
Emilia Vassilopoulou
Luminita Aurelia Stanciu
Mihnea Zdrenghea
Mihnea Zdrenghea
author_sort Gavriela Feketea
collection DOAJ
description Multisystem Inflammatory Syndrome in children (MIS-C) is a rare but devastating complication of coronavirus disease 19 (COVID-19). The development of prognostic biomarkers and more importantly the implementation of new treatment modalities would have a significant impact in clinical practice regarding the outcome of MIS-C. Vitamin D could be a potential candidate. In this mini review we analyze the immunomodulatory role of vitamin D in viral infections and specifically in COVID-19. We also examine the current literature regarding the association of vitamin D with MIS-C and Kawasaki disease. The vitamin D was evaluated not only as a biomarker but also as a nutritional supplement. We concluded that vitamin D levels could be valuable in predicting severe forms of MIS-C and correction of abnormal levels in severe MIS-C may influences its evolution. 25-hydroxyvitamin D3 [25(OH)D3] supplementation raising serum [25(OH)D] concentrations potentially have a favorable effect in reducing the severity of MIS-C in certain circumstances. Further studies are needed to confirm these results.
first_indexed 2024-12-14T17:52:51Z
format Article
id doaj.art-f559c90368374f778e5de53d54f1593a
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-14T17:52:51Z
publishDate 2021-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-f559c90368374f778e5de53d54f1593a2022-12-21T22:52:37ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-03-011210.3389/fimmu.2021.648546648546Vitamin D in Corona Virus Disease 2019 (COVID-19) Related Multisystem Inflammatory Syndrome in Children (MIS-C)Gavriela Feketea0Gavriela Feketea1Vasiliki Vlacha2Ioana Corina Bocsan3Emilia Vassilopoulou4Luminita Aurelia Stanciu5Mihnea Zdrenghea6Mihnea Zdrenghea7Department of Hematology, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, RomaniaDepartment of Pediatrics, Pediatric Allergy Outpatient Clinic, “Karamandaneio”, Children Hospital, Patras, GreeceDepartment of Early Years Learning and Care, University of Ioannina, Ioannina, GreeceDepartment of Pharmacology, Toxicology and Clinical Pharmacology, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, RomaniaDepartment of Nutritional Sciences and Dietetics International Hellenic University, Thessaloniki, GreeceNational Heart and Lung Institute, Imperial College London, London, United KingdomDepartment of Hematology, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, RomaniaIon Chiricuta Oncology Institute, Cluj-Napoca, RomaniaMultisystem Inflammatory Syndrome in children (MIS-C) is a rare but devastating complication of coronavirus disease 19 (COVID-19). The development of prognostic biomarkers and more importantly the implementation of new treatment modalities would have a significant impact in clinical practice regarding the outcome of MIS-C. Vitamin D could be a potential candidate. In this mini review we analyze the immunomodulatory role of vitamin D in viral infections and specifically in COVID-19. We also examine the current literature regarding the association of vitamin D with MIS-C and Kawasaki disease. The vitamin D was evaluated not only as a biomarker but also as a nutritional supplement. We concluded that vitamin D levels could be valuable in predicting severe forms of MIS-C and correction of abnormal levels in severe MIS-C may influences its evolution. 25-hydroxyvitamin D3 [25(OH)D3] supplementation raising serum [25(OH)D] concentrations potentially have a favorable effect in reducing the severity of MIS-C in certain circumstances. Further studies are needed to confirm these results.https://www.frontiersin.org/articles/10.3389/fimmu.2021.648546/fullvitamin D25(OH)D3SARS-CoV-2 infectionCOVID-19multisystemKawasaki syndrome-like
spellingShingle Gavriela Feketea
Gavriela Feketea
Vasiliki Vlacha
Ioana Corina Bocsan
Emilia Vassilopoulou
Luminita Aurelia Stanciu
Mihnea Zdrenghea
Mihnea Zdrenghea
Vitamin D in Corona Virus Disease 2019 (COVID-19) Related Multisystem Inflammatory Syndrome in Children (MIS-C)
Frontiers in Immunology
vitamin D
25(OH)D3
SARS-CoV-2 infection
COVID-19
multisystem
Kawasaki syndrome-like
title Vitamin D in Corona Virus Disease 2019 (COVID-19) Related Multisystem Inflammatory Syndrome in Children (MIS-C)
title_full Vitamin D in Corona Virus Disease 2019 (COVID-19) Related Multisystem Inflammatory Syndrome in Children (MIS-C)
title_fullStr Vitamin D in Corona Virus Disease 2019 (COVID-19) Related Multisystem Inflammatory Syndrome in Children (MIS-C)
title_full_unstemmed Vitamin D in Corona Virus Disease 2019 (COVID-19) Related Multisystem Inflammatory Syndrome in Children (MIS-C)
title_short Vitamin D in Corona Virus Disease 2019 (COVID-19) Related Multisystem Inflammatory Syndrome in Children (MIS-C)
title_sort vitamin d in corona virus disease 2019 covid 19 related multisystem inflammatory syndrome in children mis c
topic vitamin D
25(OH)D3
SARS-CoV-2 infection
COVID-19
multisystem
Kawasaki syndrome-like
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.648546/full
work_keys_str_mv AT gavrielafeketea vitamindincoronavirusdisease2019covid19relatedmultisysteminflammatorysyndromeinchildrenmisc
AT gavrielafeketea vitamindincoronavirusdisease2019covid19relatedmultisysteminflammatorysyndromeinchildrenmisc
AT vasilikivlacha vitamindincoronavirusdisease2019covid19relatedmultisysteminflammatorysyndromeinchildrenmisc
AT ioanacorinabocsan vitamindincoronavirusdisease2019covid19relatedmultisysteminflammatorysyndromeinchildrenmisc
AT emiliavassilopoulou vitamindincoronavirusdisease2019covid19relatedmultisysteminflammatorysyndromeinchildrenmisc
AT luminitaaureliastanciu vitamindincoronavirusdisease2019covid19relatedmultisysteminflammatorysyndromeinchildrenmisc
AT mihneazdrenghea vitamindincoronavirusdisease2019covid19relatedmultisysteminflammatorysyndromeinchildrenmisc
AT mihneazdrenghea vitamindincoronavirusdisease2019covid19relatedmultisysteminflammatorysyndromeinchildrenmisc